August 7, 2023
Two subtypes of HPV-associated head and neck cancers predict treatment outcomes
Researchers have divided HPV+ head and neck cancers into two distinct subtypes, which can help determine how well patients will respond to therapy.
August 7, 2023
Researchers have divided HPV+ head and neck cancers into two distinct subtypes, which can help determine how well patients will respond to therapy.
September 27, 2022
Adding detection of immune cell protein SYNGR3 to current protocols could lead to a more reliable way of determining which patients with head and neck cancer need less intensive treatment.